NSE: VIJAYA | BSE: 543350

Expensive Underperformer

Download real time

990.45 -9.30 (-0.93%)

33.84% Gain from 52W Low

596.3K NSE+BSE Volume

NSE 12 Dec, 2025 3:31 PM (IST)

10,174.4

Market Cap

High in industry

Beta 1Year

Low volatility

Vijaya Diagnostic Centre Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for VIJAYA, BSE:543350 Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd.

05 Jan 2022

990.45

-0.93%

B2C-focused dominant Southern player

Buy: Vijaya Diagnostic Centre Ltd.

ICICI Securities Limited

Vijaya Diagnostic (Vijaya) is one of the largest integrated diagnostic chains in southern India and is primarily based in Andhra Pradesh and Telangana. Other factors that differentiate Vijaya from other diagnostic chains are: 1) ~92% of business is its B2C (provides stickiness) and 2) it offers a comprehensive basket of diagnostic services in both pathology and radiology

Vijaya Diagnostic Ce.. has an average target of 1055.67 from 3 brokers.

Vijaya Diagnostic Centre Ltd.

01 Sep 2021

990.45

-0.93%

Vijaya Diagnostic Centre

IPO Note: Vijaya Diagnostic Centre Ltd.

Angel Broking

Vijaya Diagnostic Centre was incorporated in 2002, Company is the largest integrated diagnostic chain in southern India. Vijaya Diagnostic provides integrated services of pathology and radiology, company offers around 740 routine tests, 870 specialize pathology tests, 220 basic tests, and 320 advanced radiology tests. Vijaya diagnostic network consists of 80 diagnostic centers and 11 reference

Vijaya Diagnostic Ce.. has an average target of 1055.67 from 3 brokers.

Vijaya Diagnostic Centre Ltd.

01 Sep 2021

990.45

-0.93%

Vijaya Diagnostic Centre Ltd. IPO Note

IPO Subscribe: Vijaya Diagnostic Centre Ltd.

Ashika Research

Vijaya Diagnostic Centre Ltd. (VDCL) is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chains by revenue for FY20. The company offer an onestop solution for pathology and radiology testing services to their customers through extensive operational network, which consists of 80 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana, Andhra Pradesh, the National Capital Region and Kolkata as on June 30, 2021. For Q1FY22 and FY21, the company derived 95.91% and 96.20% of revenue from operations from the core geographies, Hyderabad and rest of Telangana and Andhra Pradesh. VDCL offers a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines, as of...

Vijaya Diagnostic Ce.. has an average target of 1055.67 from 3 brokers.

Vijaya Diagnostic Centre Ltd.

01 Sep 2021

990.45

-0.93%

Vijaya Diagnostic Centre : IPO

IPO Note: Vijaya Diagnostic Centre Ltd.

ICICI Securities Limited

Long track record of delivering consistent profitable growth For FY21, Vijaya recorded a total income of | 388.5 crore, representing a CAGR of 13.26% for FY19-20. The operating revenue per test was | 428 while OPBDIT per test was | 168 for FY20 while operating revenue per customer was | 1,214 and OPBDIT per customer was | 475 for FY20. Vijaya's...

Vijaya Diagnostic Ce.. has an average target of 1055.67 from 3 brokers.

Vijaya Diagnostic Centre Ltd.

31 Aug 2021

990.45

-0.93%

Vijaya Diagnostic Centre Limited IPO Note 31082021

IPO Note: Vijaya Diagnostic Centre Ltd.

HDFC Securities

Vijaya Diagnostic Centre Limited IPO Note Issue Open: Sep 01 Sep 03 2021 Price Band: Rs. 522 531 (Discount of Rs 52 for eligible Employees) *Issue Size: 35,688,064 eq shares (Entirely Offer for sale ) Issue Size: Rs.1862.92 1895.03 cr Reservation for: QIB Upto 17,769,031 eq sh Non Institutional atleast 5,330,710 eq sh Retail atleast 12,438,323 eq sh Employee Reservation : 150,000 eq sh